226 related articles for article (PubMed ID: 9834076)
1. Nasal immunization of nonhuman primates with simian immunodeficiency virus p55gag and cholera toxin adjuvant induces Th1/Th2 help for virus-specific immune responses in reproductive tissues.
Imaoka K; Miller CJ; Kubota M; McChesney MB; Lohman B; Yamamoto M; Fujihashi K; Someya K; Honda M; McGhee JR; Kiyono H
J Immunol; 1998 Dec; 161(11):5952-8. PubMed ID: 9834076
[TBL] [Abstract][Full Text] [Related]
2. Oral immunization with simian immunodeficiency virus p55gag and cholera toxin elicits both mucosal IgA and systemic IgG immune responses in nonhuman primates.
Kubota M; Miller CJ; Imaoka K; Kawabata S; Fujihashi K; McGhee JR; Kiyono H
J Immunol; 1997 Jun; 158(11):5321-9. PubMed ID: 9164952
[TBL] [Abstract][Full Text] [Related]
3. Mucosal Th1- versus Th2-type responses for antibody- or cell-mediated immunity to simian immunodeficiency virus in rhesus macaques.
McGhee JR; Kiyono H; Kubota M; Kawabata S; Miller CJ; Lehner T; Imaoka K; Fujihashi K
J Infect Dis; 1999 May; 179 Suppl 3():S480-4. PubMed ID: 10099124
[TBL] [Abstract][Full Text] [Related]
4. Nasopharyngeal-associated lymphoreticular tissue (NALT) immunity: fimbriae-specific Th1 and Th2 cell-regulated IgA responses for the inhibition of bacterial attachment to epithelial cells and subsequent inflammatory cytokine production.
Yanagita M; Hiroi T; Kitagaki N; Hamada S; Ito HO; Shimauchi H; Murakami S; Okada H; Kiyono H
J Immunol; 1999 Mar; 162(6):3559-65. PubMed ID: 10092814
[TBL] [Abstract][Full Text] [Related]
5. Targeted lymph node immunization with simian immunodeficiency virus p27 antigen to elicit genital, rectal, and urinary immune responses in nonhuman primates.
Lehner T; Bergmeier LA; Tao L; Panagiotidi C; Klavinskis LS; Hussain L; Ward RG; Meyers N; Adams SE; Gearing AJ
J Immunol; 1994 Aug; 153(4):1858-68. PubMed ID: 7519218
[TBL] [Abstract][Full Text] [Related]
6. Use of intranasal IL-12 to target predominantly Th1 responses to nasal and Th2 responses to oral vaccines given with cholera toxin.
Marinaro M; Boyaka PN; Jackson RJ; Finkelman FD; Kiyono H; Jirillo E; McGhee JR
J Immunol; 1999 Jan; 162(1):114-21. PubMed ID: 9886376
[TBL] [Abstract][Full Text] [Related]
7. Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4.
Marinaro M; Staats HF; Hiroi T; Jackson RJ; Coste M; Boyaka PN; Okahashi N; Yamamoto M; Kiyono H; Bluethmann H; Fujihashi K; McGhee JR
J Immunol; 1995 Nov; 155(10):4621-9. PubMed ID: 7594461
[TBL] [Abstract][Full Text] [Related]
8. Nasal immunization induces Haemophilus influenzae-specific Th1 and Th2 responses with mucosal IgA and systemic IgG antibodies for protective immunity.
Kurono Y; Yamamoto M; Fujihashi K; Kodama S; Suzuki M; Mogi G; McGhee JR; Kiyono H
J Infect Dis; 1999 Jul; 180(1):122-32. PubMed ID: 10353870
[TBL] [Abstract][Full Text] [Related]
9. Mucosal or targeted lymph node immunization of macaques with a particulate SIVp27 protein elicits virus-specific CTL in the genito-rectal mucosa and draining lymph nodes.
Klavinskis LS; Bergmeier LA; Gao L; Mitchell E; Ward RG; Layton G; Brookes R; Meyers NJ; Lehner T
J Immunol; 1996 Sep; 157(6):2521-7. PubMed ID: 8805653
[TBL] [Abstract][Full Text] [Related]
10. HIV mucosal vaccine: nasal immunization with gp160-encapsulated hemagglutinating virus of Japan-liposome induces antigen-specific CTLs and neutralizing antibody responses.
Sakaue G; Hiroi T; Nakagawa Y; Someya K; Iwatani K; Sawa Y; Takahashi H; Honda M; Kunisawa J; Kiyono H
J Immunol; 2003 Jan; 170(1):495-502. PubMed ID: 12496436
[TBL] [Abstract][Full Text] [Related]
11. Selective induction of protective MHC class I-restricted CTL in the intestinal lamina propria of rhesus monkeys by transient SIV infection of the colonic mucosa.
Murphey-Corb M; Wilson LA; Trichel AM; Roberts DE; Xu K; Ohkawa S; Woodson B; Bohm R; Blanchard J
J Immunol; 1999 Jan; 162(1):540-9. PubMed ID: 9886431
[TBL] [Abstract][Full Text] [Related]
12. Acceleration of influenza virus clearance by Th1 cells in the nasal site of mice immunized intranasally with adjuvant-combined recombinant nucleoprotein.
Tamura S; Miyata K; Matsuo K; Asanuma H; Takahashi H; Nakajima K; Suzuki Y; Aizawa C; Kurata T
J Immunol; 1996 May; 156(10):3892-900. PubMed ID: 8621928
[TBL] [Abstract][Full Text] [Related]
13. A novel adjuvant for mucosal immunity to HIV-1 gp120 in nonhuman primates.
Yoshino N; Lü FX; Fujihashi K; Hagiwara Y; Kataoka K; Lu D; Hirst L; Honda M; van Ginkel FW; Takeda Y; Miller CJ; Kiyono H; McGhee JR
J Immunol; 2004 Dec; 173(11):6850-7. PubMed ID: 15557179
[TBL] [Abstract][Full Text] [Related]
14. A nontoxic adjuvant for mucosal immunity to pneumococcal surface protein A.
Yamamoto M; Briles DE; Yamamoto S; Ohmura M; Kiyono H; McGhee JR
J Immunol; 1998 Oct; 161(8):4115-21. PubMed ID: 9780183
[TBL] [Abstract][Full Text] [Related]
15. Live varicella vaccine polarizes the mucosal adjuvant action of cholera toxin or its B subunit on specific Th1-type helper T cells with a single nasal coadministration in mice.
Sasaki K; Kato M; Takahashi T; Ochi S; Ichinose Y; Shiraki K; Asano Y; Iwanaga M; Tsuji T
J Med Virol; 2003 Jun; 70(2):329-35. PubMed ID: 12696126
[TBL] [Abstract][Full Text] [Related]
16. Mucosal immunity: regulation by helper T cells and a novel method for detection.
Jackson RJ; Marinaro M; VanCott JL; Yamamoto M; Okahashi N; Fujihashi K; Kiyono H; Chatfield SN; McGhee JR
J Biotechnol; 1996 Jan; 44(1-3):209-16. PubMed ID: 8717406
[TBL] [Abstract][Full Text] [Related]
17. IL-12 is an effective adjuvant for induction of mucosal immunity.
Boyaka PN; Marinaro M; Jackson RJ; Menon S; Kiyono H; Jirillo E; McGhee JR
J Immunol; 1999 Jan; 162(1):122-8. PubMed ID: 9886377
[TBL] [Abstract][Full Text] [Related]
18. Induction of Th2 cytokine expression for p27-specific IgA B cell responses after targeted lymph node immunization with simian immunodeficiency virus antigens in rhesus macaques.
Kawabata S; Miller CJ; Lehner T; Fujihashi K; Kubota M; McGhee JR; Imaoka K; Hiroi T; Kiyono H
J Infect Dis; 1998 Jan; 177(1):26-33. PubMed ID: 9419166
[TBL] [Abstract][Full Text] [Related]
19. A comparative evaluation of nasal and parenteral vaccine adjuvants to elicit systemic and mucosal HIV-1 peptide-specific humoral immune responses in cynomolgus macaques.
Egan MA; Chong SY; Hagen M; Megati S; Schadeck EB; Piacente P; Ma BJ; Montefiori DC; Haynes BF; Israel ZR; Eldridge JH; Staats HF
Vaccine; 2004 Sep; 22(27-28):3774-88. PubMed ID: 15315859
[TBL] [Abstract][Full Text] [Related]
20. Oral administration of cholera toxin-Sendai virus conjugate potentiates gut and respiratory immunity against Sendai virus.
Liang XP; Lamm ME; Nedrud JG
J Immunol; 1988 Sep; 141(5):1495-501. PubMed ID: 2842395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
